A Registry of Biospecimens for Patients with Central Nervous Systems Inflammatory Disease

Overview

About this study

The purpose of the study is to learn more about inflammatory diseases of the central nervous system (CNS) by collecting patient information, blood sample (which contain a person’s genes, DNA) and other available tissue samples.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

  • Pathological diagnosis CNS inflammatory demyelinating disease (IIDD) consistent with MS, confirmed by a pathologist
  • FFPE tissue with sufficient area for pathological analyses

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Claudia Lucchinetti, M.D.

Open for enrollment

Contact information:

Linda Linbo R.N.

(507) 266-2470

llinbo@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20164328

Mayo Clinic Footer